MarketStudyReport.com adds “Global Atenolol Market Outlook 2016-2021” new report to its research database. The report spread across 99 pages with table and figures in it.
Atenolol is a selective ?1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written ?-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not readily pass through the blood?brain barrier, thus decreasing the incidence of central nervous system side effects.
Atenolol is one of the most widely used ?-blockers in the United Kingdom and was once the first-line treatment for hypertension. However, recent studies indicate that atenolol may not reduce morbidity or mortality when used to treat hypertension, and may even increase mortality in some subgroups. In addition, the role for ?-blockers in general in hypertension was downgraded in June 2006 in the United Kingdom, and later in the United States, as they are less appropriate than newer drugs, particularly in the elderly.
Browse full table of contents and data tables @ https://www.marketstudyreport.com/reports/global-atenolol-market-outlook-2016-2021/
This report provides detailed analysis of worldwide markets for Atenolol from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Atenolol market and further lays out an analysis of the factors influencing the supply/demand for Atenolol, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Atenolol Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Atenolol market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Atenolol market are KOPRAN (India), AMRI India (India), Ipca Laboratories (India), Ipca (India), CFM Group (Italy), Teva (Israel), Chifeng Arker (China), among others.
To receive personalized assistance, write to us @ email@example.com with the report title in the subject line along with your questions or call us at +1 866-764-2150